Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Deep Lens Closes $14M Series A Financing To Further Advance Digital Ai Pathology Platform For Clinical Trial Recruitment
Venture Capital

Deep Lens Closes $14M Series A Financing To Further Advance Digital Ai Pathology Platform For Clinical Trial Recruitment

by vcaonline.com posted 4months ago 216 views
Deep Lens Closes $14 Million Series A Financing to Further Advance Digital AI Pathology Platform for Clinical Trial Recruitment COLUMBUS, Ohio, April 8, 2019-- Deep Lens, Inc., an AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis, announced today the company has closed a $14 million Series A financing, led by Northpond Ventures. Existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners also participated in this round, which comes just three months after Deep Lens closed its VC-led seed equity round. Funding to date now totals $17.5 million.

In this article